Aditx Therapeutics (ADTX)
(Delayed Data from NSDQ)
$2.09 USD
+0.08 (3.98%)
Updated May 20, 2024 03:59 PM ET
After-Market: $2.01 -0.08 (-3.83%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 36% (83 out of 248)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | -3.33 | 0.39 | 57.00 |
Year Ago Quarter Estimate | -52.40 | -0.79 | 52.54 |
Next Quarter Estimate | -2.69 | -2.04 | 61.00 |
Next Year Estimate | NA | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 89.56 | 12.40 | 15.67 |
Next Year | NA | 14.90 | 9.31 |
Last 5 Years | NA | 4.90 | 8.10 |
Next 5 Years | NA | 22.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 0.03 | 1.86 |
Price/Cash Flow (MRFY) | NA | 8.87 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -5,016.31% | -61.28% |
Return on Equity (TTM) | -1,614.64% | -52.46% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.